Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts

Nature

Volumn 510, Issue 7504, 2014, Pages 273-277

  Chong, James J H ^a,b,c,f   Yang, Xiulan ^a   Don, Creighton W ^a   Minami, Elina ^a   Liu, Yen Wen ^a   Weyers, Jill J ^a   Mahoney, William M ^a   Van Biber, Benjamin ^a   Cook, Savannah M ^a   Palpant, Nathan J ^a   Gantz, Jay A ^a,d   Fugate, James A ^a   Muskheli, Veronica ^a   Gough, G Michael ^a   Vogel, Keith W ^a   Astley, Cliff A ^a   Hotchkiss, Charlotte E ^a   Baldessari, Audrey ^a   Pabon, Lil ^a   Reinecke, Hans ^a   Gill, Edward A ^a   Nelson, Veronica ^e   Kiem, Hans Peter ^a,e   Laflamme, Michael A ^a   Murry, Charles E ^a,d   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d University of Washington   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

CALCIUM; CELL ORGANELLE; CRYOPRESERVATION; EMBRYONIC DEVELOPMENT; NUMERICAL MODEL; PRIMATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; ELECTROCARDIOGRAM; EMBRYONIC STEM CELL; ENGRAFTMENT; EXCITATION CONTRACTION COUPLING; FEMALE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; MACACA; MALE; NONHUMAN; PRIMATE; PRIORITY JOURNAL;

ANIMALIA; PRIMATES;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CELL SURVIVAL; CORONARY VESSELS; CRYOPRESERVATION; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; EMBRYONIC STEM CELLS; HEART; HUMANS; MACACA NEMESTRINA; MALE; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; REGENERATION; REGENERATIVE MEDICINE;

EID: 84902312015     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13233     Document Type: Article

References (30)

1. Lozano, R. et al. Global and regionalmortality from235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2012).
2. Laflamme, M. A. & Murry, C. E. Heart regeneration. Nature 473, 326-335 (2011).
3. Caspi, O. et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50, 1884-1893 (2007).
4. van Laake, L. W. et al. Humanembryonic stemcell-derived cardiomyocytes survive andmature in themouse heart and transiently improve function after myocardial infarction. Stem Cell Res. (Amst.) 1, 9-24 (2007).
5. Laflamme, M. A. et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167, 663-671 (2005).
6. Fernandes, S. et al. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J. Mol. Cell. Cardiol. 49, 941-949 (2010).
7. Shiba, Y. et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325 (2012).
8. Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnol. 25, 1015-1024 (2007).
9. Blin, G. et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J. Clin. Invest. 120, 1125-1139 (2010).
10. Bel, A. et al. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 122, S118-S123 (2010).
11. Yang, X., Pabon, L. & Murry, C. E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511-523 (2014).
12. Mauritz, C. et al. Induced pluripotent stemcell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur. Heart J. 32, 2634-2641 (2011).
13. Schwartz, S. D. et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713-720 (2012).
14. Bretzner, F., Gilbert, F., Baylis, F.&Brownstone, R. M. Target populations for first-inhuman embryonic stem cell research in spinal cord injury. Cell Stem Cell 8, 468-475 (2011).
15. Robey, T. E., Saiget, M. K., Reinecke, H. & Murry, C. E. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 45, 567-581 (2008).
16. Xu, C. et al. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regen. Med. 6, 53-66 (2011).
17. Hoshino, T., Fujiwara, H., Kawai, C.&Hamashima, Y. Myocardial fiber diameter and regional distribution in the ventricular wall of normal adult hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 67, 1109-1116 (1983).
18. Gandolfi, F. et al. Large animal models for cardiac stem cell therapies. Theriogenology 75, 1416-1425 (2011).
19. van der Spoel, T. I. et al. Human relevance of pre-clinical studies in stem cell therapy: systematic reviewandmeta-analysis of large animalmodels of ischaemic heart disease. Cardiovasc. Res. 91, 649-658 (2011).
20. Kehat, I. et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nature Biotechnol. 22, 1282-1289 (2004).
21. Chen, H. S., Kim, C. & Mercola, M. Electrophysiological challenges of cell-based myocardial repair. Circulation 120, 2496-2508 (2009).
22. Dixon, J. A.&Spinale, F. G. Large animalmodels of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail 2, 262-271 (2009).
23. Weyers, J. J. et al. Effects of cell grafting on coronary remodeling after myocardial infarction. J. Am. Heart Assoc. 2, e000202 (2013).
24. Gantz, J. A. et al. Targeted genomic integration of a selectable floxed dual fluorescence reporter in human embryonic stem cells. PLoS ONE 7, e46971 (2012).
25. Xu, C. et al. Feeder-free growth of undifferentiated human embryonic stemcells. Nature Biotechnol. 19, 971-974 (2001).
26. Zhu, W. Z., Van Biber, B. & Laflamme, M. A. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Methods Mol. Biol. 767, 419-431 (2011).
27. Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nature Biotechnol. 27, 851-857 (2009).
28. Biermann, M. et al. Differential effects of cytochalasin D and 2,3 butanedione monoxime on isometric twitch force and transmembrane action potential in isolated ventricular muscle: implications for optical measurements of cardiac repolarization. J. Cardiovasc. Electrophysiol. 9, 1348-1377 (1998).
29. Laurita, K. R. & Singal, A. Mapping action potentials and calcium transients simultaneously from the intact heart. Am. J. Physiol. Heart Circ. Physiol. 280, H2053-H2060 (2001).
30. Chong, J. J. H. et al. Progenitor cells identified by PDGFR-a expression in the developing and diseased human heart. Stem Cells Dev. 22, 1932-1943 (2013).